Correlation Engine 2.0
Clear Search sequence regions

  • arthropod (1)
  • bacteria (1)
  • human (5)
  • insects (1)
  • ivermectin (7)
  • protozoans (1)
  • research (3)
  • strongyloidiasis (1)
  • Sizes of these terms reflect their relevance to your search.

    Parasitic diseases still pose a serious threat to human and animal health, particularly for millions of people and their livelihoods in low-income countries. Therefore, research into the development of effective antiparasitic drugs remains a priority. Ivermectin, a sixteen-membered macrocyclic lactone, exhibits a broad spectrum of antiparasitic activities, which, combined with its low toxicity, has allowed the drug to be widely used in the treatment of parasitic diseases affecting humans and animals. In addition to its licensed use against river blindness and strongyloidiasis in humans, and against roundworm and arthropod infestations in animals, ivermectin is also used "off-label" to treat many other worm-related parasitic diseases, particularly in domestic animals. In addition, several experimental studies indicate that ivermectin displays also potent activity against viruses, bacteria, protozoans, trematodes, and insects. This review article summarizes the last 40 years of research on the antiparasitic effects of ivermectin, and the use of the drug in the treatment of parasitic diseases in humans and animals. Copyright © 2023 The Authors. Published by Elsevier Masson SAS.. All rights reserved.


    Michał Sulik, Michał Antoszczak, Adam Huczyński, Dietmar Steverding. Antiparasitic activity of ivermectin: Four decades of research into a "wonder drug". European journal of medicinal chemistry. 2023 Dec 05;261:115838

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 37793327

    View Full Text